PPP1R1A
Basic information
Region (hg38): 12:54575387-54588659
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP1R1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 12 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 1 | 0 |
Variants in PPP1R1A
This is a list of pathogenic ClinVar variants found in the PPP1R1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-54575599-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
12-54576038-C-G | not specified | Uncertain significance (Feb 07, 2025) | ||
12-54576057-C-G | not specified | Uncertain significance (Jun 18, 2021) | ||
12-54576061-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
12-54576066-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
12-54576605-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
12-54576639-G-A | not specified | Uncertain significance (May 08, 2024) | ||
12-54576645-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
12-54576690-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
12-54577260-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
12-54577261-C-G | not specified | Uncertain significance (May 24, 2023) | ||
12-54577281-C-G | not specified | Uncertain significance (Apr 18, 2023) | ||
12-54580992-T-A | not specified | Uncertain significance (Jan 26, 2023) | ||
12-54580997-T-C | not specified | Uncertain significance (May 26, 2023) | ||
12-54581054-G-A | Benign (Jul 06, 2018) | |||
12-54581984-G-C | not specified | Uncertain significance (Jul 08, 2022) | ||
12-54582006-AC-TG | Rosette-forming glioneuronal tumor | Uncertain significance (-) | ||
12-54582012-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
12-54582039-G-A | not specified | Likely benign (Dec 18, 2023) | ||
12-54582069-C-T | Low-frequency hearing loss;Low-frequency sensorineural hearing impairment • not specified | Conflicting classifications of pathogenicity (Dec 14, 2024) | ||
12-54582783-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
12-54583233-C-T | not specified | Uncertain significance (Dec 10, 2024) | ||
12-54584275-C-G | not specified | Uncertain significance (Jun 18, 2024) | ||
12-54588415-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
12-54588425-C-G | not specified | Uncertain significance (Dec 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPP1R1A | protein_coding | protein_coding | ENST00000257905 | 7 | 13273 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0219 | 0.916 | 124645 | 0 | 9 | 124654 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.977 | 66 | 92.4 | 0.714 | 0.00000518 | 1080 |
Missense in Polyphen | 28 | 38.255 | 0.73194 | 470 | ||
Synonymous | -0.628 | 36 | 31.5 | 1.14 | 0.00000160 | 330 |
Loss of Function | 1.59 | 4 | 9.21 | 0.435 | 3.93e-7 | 119 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000599 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.0000599 | 0.0000556 |
South Asian | 0.000261 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibitor of protein-phosphatase 1. This protein may be important in hormonal control of glycogen metabolism. Hormones that elevate intracellular cAMP increase I-1 activity in many tissues. I-1 activation may impose cAMP control over proteins that are not directly phosphorylated by PKA. Following a rise in intracellular calcium, I-1 is inactivated by calcineurin (or PP2B). Does not inhibit type-2 phosphatases.;
- Pathway
- Long-term potentiation - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Common Pathways Underlying Drug Addiction
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.736
- rvis_EVS
- 0.61
- rvis_percentile_EVS
- 83.07
Haploinsufficiency Scores
- pHI
- 0.454
- hipred
- N
- hipred_score
- 0.199
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0370
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppp1r1a
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- glycogen metabolic process;negative regulation of phosphoprotein phosphatase activity;intracellular signal transduction
- Cellular component
- extracellular space;cytoplasm
- Molecular function
- protein serine/threonine phosphatase inhibitor activity;protein binding